Please assess the completion status of the following clinical trial:

Trial Title: Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with schizophrenia and schizophrenia-related insomnia, no relapse or psychosis for at least 3 months before screening, and considered symptomatically stable~* have apnea/hypopnea score \<10 and periodic leg movement score with an arousal index \<10~* Weigh \>/= 50 kg (\>/=110 lbs), with a BMI \>/= 18 and \</= 35 kg/m2, inclusive~* Agree to adhere to sleep schedule~* Have a sleep history of a minimum of 1.5 hours of wakefulness out of 8 hours in bed.~Exclusion Criteria:~* Current history of suicidal or violent behavior or have exhibited this behavior within the past 6 months~* diagnosis of primary insomnia~* unstable blood pressure~* sleep problems related to general medical conditions, or substance abuse~* diagnosis of or evidence of narcolepsy~* preexisting severe gastrointestinal narrowing.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).